基于FDA不良事件报告系统对与药物相关的雷诺现象进行全面研究
Pingping Zheng1, Xiulian Zheng2, Qun Chen3
1First School of Clinical Medicine, Fujian University of Chinese Medicine, Fuzhou, China.
Scientific reports
|September 1, 2025
概括
这项研究确定了562种与雷诺病相关的药物.
科学领域:
- 药物监督管理
- 药物安全
- 临床药理学
背景情况:
- 雷诺现象 (RP),特别是二次RP,可以被药物诱导或恶化.
- 识别与药物相关的RP对于预防和管理至关重要.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 系统地评估与雷诺现象的药物相关性.
- 量化RP相关药物的风险,并确定特定的药物类别和适用情况.
主要方法:
- 对FAERS数据进行不成比例分析以确定与RP相关的药物.
- 根据解剖治疗化学 (ATC) 分类进行分类.
- 描述性和次要分析,包括对时间模式的韦布尔形状参数测试.
主要成果:
- 发现了562种药物和4303种RP病例.
- 在神经系统,心血管和免疫调节剂中发现了显著的关联.
- CGRP 抑制剂,类药物,β 阻断剂,干扰素和抗瘤药物具有很高的相关性.
- 常见的相关症状是风湿性关节炎,麻醉症和ADHD.
- 主要发生在25至59岁的女性中.
结论:
- 这项研究系统地报告了药物与RP的关联,强调了可预防的风险.
- 临床医生应对包括CGRP抑制剂和三剂在内的特定药物类别的RP风险进行监测.
- 对于中年和老年女性,特别是患有类风湿性关节炎的女性,建议对药物诱导的RP保持高度警.
相关概念视频
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
673
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
673
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K


